TSXV:CLAS.H - Post by User
Post by
Enzolinion Apr 22, 2018 10:31am
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
135 Views
Post# 27923105
March 7 Post by KING "George"
March 7 Post by KING "George"Well some of these points have happened, now its a waiting game for the rest!!!! Great potential
Spoke with Rob Farrell last night - here are the take aways:
1) Branch out will be not only cover GvHD with CBD - more clinical trials will be happening in paralel which will be leading to more news more often. Both companies are very reputable (one is Canadian) but no more can be said and we can't know until news is released. The branch out is because of the success of the GvHD trials and has nothing to do with "a backup" plan of some sort.
2) U.S. Patent that was Granted will be issued any day now. PR will be made the moment it is issued (could be any day).
3) There will be a couple more payments to Salzman via common shares.
4) Branch out news will be a good news letter to investors followed by some more good news there after.
5) GvHD clinical trials are going great and patients so far are seeing positive effects in Phase 2.
6) Share price will be effected for the better in the near future.
here people.
Spoke with Rob Farrell last night - here are the take aways:
1) Branch out will be not only cover GvHD with CBD - more clinical trials will be happening in paralel which will be leading to more news more often. Both companies are very reputable (one is Canadian) but no more can be said and we can't know until news is released. The branch out is because of the success of the GvHD trials and has nothing to do with "a backup" plan of some sort.
2) U.S. Patent that was Granted will be issued any day now. PR will be made the moment it is issued (could be any day).
3) There will be a couple more payments to Salzman via common shares.
4) Branch out news will be a good news letter to investors followed by some more good news there after.
5) GvHD clinical trials are going great and patients so far are seeing positive effects in Phase 2.
6) Share price will be effected for the better in the near future.